hydralazine has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birnbaum, B | 1 |
| Sidhu, GS | 1 |
| Smith, RL | 1 |
| Pillinger, MH | 1 |
| Tagoe, CE | 1 |
1 other study available for hydralazine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Fulminating hydralazine-induced lupus pneumonitis.
Topics: Adult; Antihypertensive Agents; Fatal Outcome; Female; Humans; Hydralazine; Lung; Lung Diseases, Int | 2006 |